Data gathered: May 17
Alternative Data for Danaher
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 54 | Sign up | Sign up | Sign up |
| Sentiment | 100 | Sign up | Sign up | Sign up |
| Webpage traffic | 421,000 | Sign up | Sign up | Sign up |
| Employee Rating | 74 | Sign up | Sign up | Sign up |
| Google Trends | 44 | Sign up | Sign up | Sign up |
| Patents | 1,137 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Facebook Engagement | 35 | Sign up | Sign up | Sign up |
| Facebook Followers | 10,912 | Sign up | Sign up | Sign up |
| Instagram Followers | 6,061 | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 1 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 4,359 | Sign up | Sign up | Sign up |
| Twitter Followers | 1,468 | Sign up | Sign up | Sign up |
| Twitter Mentions | 89 | Sign up | Sign up | Sign up |
| Youtube Subscribers | 3,280 | Sign up | Sign up | Sign up |
| News Mentions | 2 | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| ESG | 77 | Sign up | Sign up | Sign up |
| Business Outlook | 75 | Sign up | Sign up | Sign up |
| Linkedin Employees | 51,548 | Sign up | Sign up | Sign up |
About Danaher
Danaher is a global science and technology innovator committed to helping its customers solve complex challenges and improve quality of life around the world.
| Price | $264.84 |
| Target Price | Sign up |
| Volume | 3,440,000 |
| Market Cap | $195B |
| Year Range | $184.71 - $264.84 |
| Dividend Yield | 0.41% |
| PE Ratio | 48.34 |
| Revenue per Employee | $330,468 |
| Industry | Medical & Dental Instruments |
In the news
 |
Danaher Co. (NYSE:DHR) CFO Sells $11,735,699.85 in StockMay 16 - ETF Daily News |
Danaher's rally shows how sticking with a troubled stock of a good company can pay offMay 15 - CNBC |
|
Global Flow Cytometry Market Report 2024-2029, Featuring Agilent Technologies, BD, Bio-Rad Laboratories, Cytek Biosciences, Danaher, Miltenyi Biotec, Sony Biotechnology and Standard BiotoolsMay 15 - GlobeNewswire |
|
|
Q2 2024 EPS Estimates for Danaher Co. (NYSE:DHR) Cut by AnalystMay 15 - ETF Daily News |
 |
Danaher (DHR) Rides on Business Strength Amid HeadwindsMay 15 - Yahoo |
Danaher Corp: An Exploration into Its Intrinsic ValueMay 14 - GuruFocus |
|
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q1 '24 | 5.69B | 4.52B | 3.49B | 1.09B | 1.74B | 1.920 |
| Q4 '23 | 6.41B | 2.29B | 3.78B | 1.08B | 1.42B | 2.090 |
| Q3 '23 | 6.92B | 5.02B | 3.28B | 1.13B | 1.85B | 2.020 |
| Q2 '23 | 7.09B | 5.36B | 3.32B | 1.11B | 1.84B | 2.050 |
| Q1 '23 | 7.1B | 5.33B | 3.66B | 1.45B | 2.25B | 2.360 |
Insider Transactions View All
| Blair Rainer filed to sell 115,995 shares at $255. May 15 '24 |
| McGrew Matthew filed to sell 29,407 shares at $253.2. May 13 '24 |
| McGrew Matthew filed to sell 29,407 shares at $252.9. May 13 '24 |
| McGrew Matthew filed to sell 29,407 shares at $253.1. May 13 '24 |
| SPOON ALAN G filed to sell 116,202 shares at $243.6. May 3 '24 |
Similar companies
| Company | Price | AI Score | |
|---|---|---|---|
 |
Align TechnologyALGN |
$273.56 0% | 51 |
 |
DentsplyXRAY |
$28.38 0% | 46 |
 |
LeMaitre VascularLMAT |
$77.68 0% | 53 |
 |
iRhythm TechnologiesIRTC |
$98.7 0% | 35 |
 |
NovoCureNVCR |
$22.17 0% | 50 |
Congress Trading View All
| Politician | Filing Date | Type | Size |
|---|---|---|---|
| Rohit Khanna Democrat |
May 6, 24 | Buy | $15K - $50K |
| Rohit Khanna Democrat |
May 6, 24 | Sell | $1K - $15K |
| Daniel Newhouse Republican |
Apr 25, 24 | Buy | $1K - $15K |
Read more about Danaher (DHR) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, youtube subscribers, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of Danaher?
The Market Cap of Danaher is $195B.
What is Danaher's PE Ratio?
As of today, Danaher's PE (Price to Earnings) ratio is 48.34.
How Many People Work at Danaher?
As of our latest update, Danaher employed approximately 79,000 people worldwide. However, it's important to note that Danaher's workforce size can fluctuate due to the company's growth, restructuring, or strategic shifts, so the current number of employees may be different.
What is Danaher's revenue per employee?
$330,468. To calculate Danaher's revenue per employee, we divide the company's total revenue in the last 4 quarters by its total number of employees.
What is the current stock price of Danaher?
Currently, the price of one share of Danaher stock is $264.84.
How can I analyze the DHR stock price chart for investment decisions?
The DHR stock price chart above provides a comprehensive visual representation of Danaher's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Danaher shares. Our platform offers an up-to-date DHR stock price chart, along with technical data analysis and alternative data insights.
Does DHR offer dividends to its shareholders?
Yes, Danaher (DHR) offers dividends to its shareholders, with a dividend yield of 0.41%. This dividend yield represents Danaher's commitment to providing value to its shareholders through both potential capital appreciation and steady income. Investors considering Danaher in their portfolio should factor in this dividend policy alongside the company's growth prospects and market position.
What are some of the similar stocks of Danaher?
Some of the similar stocks of Danaher are Align Technology, Dentsply, LeMaitre Vascular, iRhythm Technologies, and NovoCure.
.